11/12
09:25 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/12
09:25 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
02:42 pm
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
02:42 pm
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
01:09 pm
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
01:09 pm
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
11:15 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
11:15 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
11/8
08:46 am
lgnd
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $157.00 price target on the stock.
Low
Report
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $157.00 price target on the stock.
10/31
10:42 am
lgnd
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $157.00 price target on the stock.
Low
Report
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $157.00 price target on the stock.
10/28
10:03 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
10/28
10:03 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
10/3
08:17 am
lgnd
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $135.00 price target on the stock.
Low
Report
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $135.00 price target on the stock.
10/3
08:03 am
lgnd
Rating for LGND
Low
Report
Rating for LGND
10/3
08:03 am
lgnd
Rating for LGND
Low
Report
Rating for LGND